Dyne Therapeutics, Inc.DYNNASDAQ

Revenue (LTM)

Net Income (LTM)

$-446M

-40.6% YoY

Free Cash Flow

$-405M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.4B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	-2	-2↑8.9%	-2↑8.6%
Operating Income	-150	-171↓14.0%	-242↓41.6%	-344↓42.0%	-468↓36.1%
Net Income	-149	-168↓12.6%	-236↓40.4%	-317↓34.5%	-446↓40.6%
EBITDA	-149	-169↓13.7%	-233↓37.9%	-315↓35.0%	-438↓39.0%
EPS Diluted	-2.93	-3.23↓10.2%	-3.95↓22.3%	-3.37↑14.7%	-3.47↓3.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	201	172↓14.3%	122↓29.3%	435↑258.0%	893↑105.2%
Total Current Assets	382	266↓30.5%	129↓51.3%	659↑409.6%	1,127↑70.9%
Total Assets	426	306↓28.0%	165↓46.1%	691↑318.7%	1,187↑71.7%
Total Current Liabilities	29	28↓2.2%	51↑81.9%	42↓17.3%	51↑19.8%
Total Liabilities	57	54↓6.1%	74↑36.7%	61↓16.8%	215↑249.9%
Total Equity	368	252↓31.5%	91↓63.8%	630↑589.9%	972↑54.3%
Total Debt	33	30↓6.6%	27↓10.1%	24↓12.5%	20↓15.5%
Net Debt	-168	-142↑15.8%	-94↑33.5%	-411↓336.7%	-873↓112.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-120	-154↓28.5%	-188↓22.5%	-292↓55.4%	-403↓37.9%
Capital Expenditure	-4	-3↑15.2%	-1↑76.2%	-2↓225.9%	-2↑19.2%
Free Cash Flow	-123	-157↓27.2%	-189↓20.5%	-295↓56.0%	-405↓37.4%
Stock-Based Comp	18	15↓13.5%	20↑31.6%	46↑129.6%	46↓0.0%
Net Change in Cash	-100	-29↑70.8%	-51↓73.9%	313↑720.4%	458↑46.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance